Healthcare
Healthcare Plans
$78.55B
72.5K
The Cigna Group is a global health company committed to creating a better future built on the vitality of every individual and every community. They offer a differentiated set of pharmacy, medical, behavioral, dental and related products and services, primarily through employers and other groups. The company has a significant presence in the U.S. and international markets, with a focus on improving health outcomes and affordability.
Key insights and themes extracted from this filing
The Cigna Group reported adjusted revenues of $195.3 billion for 2023, an 8% increase compared to $180.6 billion in 2022. This growth was driven by both Evernorth Health Services and Cigna Healthcare segments.
The Company's shareholders' net income decreased to $5.2 billion in 2023, compared to $6.7 billion in 2022. This decrease was primarily due to the estimated loss associated with the sale of the Medicare Advantage and related businesses to HCSC.
Pre-tax adjusted income from operations increased to $9.3 billion in 2023, a 2% increase compared to $9.3 billion in 2022. This increase was driven by the Evernorth Health Services and Cigna Healthcare segments.
The Company approved a strategic realignment to drive greater operating effectiveness and efficiency. This plan positions the company to be more efficient and focused to deliver differentiated value and services to our clients and customers.
In January 2024, the Company entered into a definitive agreement to sell its Medicare Advantage, Medicare Stand-Alone Prescription Drug Plans, Medicare and Other Supplemental Benefits and CareAllies businesses to HCSC for $3.3 billion in cash.
The Company continues to expand the breadth and depth of the Evernorth Health Services pharmacy benefit services and specialty and care services available to Cigna Healthcare clients and customers to deliver value by improving affordability, access, quality of care, care innovations and transparency.
The Company's investments in digital, data and technology are focused on cultivating robust digital-first capabilities to better engage with customers and stakeholders. The Company continues to invest in technology capabilities to produce new and more effective ways to operate.
The Company continues to transform and improve the way health care is delivered through automation, advanced analytics and Artificial Intelligence (AI) technologies. The Company utilizes these technologies to analyze data and uncover patterns and insights to help improve outcomes.
The Company continues to invest in its global workforce to support its employees' health and well-being, further drive diversity and inclusion, provide fair and market-competitive pay and foster employee growth and development.
The Company and its vendors are subject to cyberattacks or other privacy or data security incidents. If the Company is unable to prevent or contain the effects of any such attacks, or fail to ensure vendors do the same, it may suffer exposure to substantial liability, reputational harm, loss of revenue or other damages.
The laws and regulations governing the business continue to increase each year and are subject to frequent change. The Company is regulated by federal, state and international legislative bodies and agencies, which generally have discretion to issue regulations and interpret and enforce laws and rules.
Economic and market conditions affect the value of the Company's financial instruments and the value of particular assets and liabilities, investment income and interest expense. The Company's investment results are affected by the amount and timing of cash available for investment, economic and market conditions and asset allocation decisions.
The health care industry has undergone periods of substantial consolidation and may continue to consolidate in the future. Many of the largest managed care organizations now also own health services businesses that compete with Evernorth Health Services in the verticals in which it participates.
The Company believes its focus on improving the health and vitality of those it serves will allow it to further differentiate itself from its primary competitors.
The Company enters into a variety of provider partnerships to continuously improve the quality of care for those it serves. This includes collaborative care arrangements with primary care groups and specialist programs.
The Company approved a strategic realignment to drive greater operating effectiveness and efficiency. This plan positions the company to be more efficient and focused to deliver differentiated value and services to our clients and customers.
The Company continues to transform and improve the way health care is delivered through automation, advanced analytics and Artificial Intelligence (AI) technologies. The Company utilizes these technologies to analyze data and uncover patterns and insights to help improve outcomes, increase connectivity between the patient and the health care system, and speed up administrative processes.
Cost Containment Programs are designed to contain the cost of covered health care services and supplies. These programs reduce out-of-network utilization and costs, protect customers from balance billing and educate customers regarding the availability of lower cost in-network services.
The Company's investments in digital, data and technology are focused on cultivating robust digital-first capabilities to better engage with customers and stakeholders. The Company delivers value for its clients, customers and other stakeholders by creating better health outcomes, improving customer experience and lowering total cost of care.
The Company utilizes AI and machine learning technologies to analyze data and uncover patterns and insights to help improve outcomes, increase connectivity between the patient and the health care system, speed up administrative processes, and improve the overall member experience.
Cybersecurity protections continue to be a top priority across The Cigna Group's digital offerings to further strengthen its security posture and grow the trust of those it serves. The Company continues to invest in its cybersecurity practices and governance.
In December 2023, the Board increased repurchasing authority by an additional $10.0 billion. In February 2024, as part of the existing share repurchase program, the Company entered into accelerated share repurchase agreements to repurchase $3.2 billion of common stock in aggregate.
Capital expenditures for property, equipment and computer software were $1.6 billion in 2023 compared to $1.3 billion in the year ended December 31, 2022. This increase reflects the Company's continued strategic investment in technology for future growth.
The Cigna Group declared and paid quarterly cash dividends of $1.23 per share of its common stock during 2023. On February 2, 2024, the Board of Directors declared the first quarter cash dividend of $1.40 per share of The Cigna Group common stock to be paid on March 21, 2024.
The Cigna Group's environmental, social and governance (ESG) framework is structured around four connected pillars that underscore its enterprise mission to improve the health and vitality of those it serves. These pillars are: Healthy Society, Healthy Workforce, Healthy Environment and Healthy Company.
The Company is committed to attracting and recruiting key diverse talent into various leadership development programs and other entry level positions across the business. This success is rooted in strategic relationships with student groups at partner colleges and universities.
The Company believes that responsible environmental stewardship can improve health and vitality and also makes sound business sense. The Company strives to identify new efficiencies and make strategic investments that reduce its environmental impacts and its operating costs.
The health care industry has undergone periods of substantial consolidation and may continue to consolidate in the future. Many of the largest managed care organizations now also own health services businesses that compete with Evernorth Health Services in the verticals in which it participates.
The Company expects continued legislative and regulatory debate of issues related to its businesses. As has become increasingly common with public policy reforms in the health services industry, executive, judicial or legislative intervention could alter, slow or eliminate the impact of any proposal following the related regulation's promulgation.
The Company continues to monitor global economic conditions, including inflation, labor market dynamics and recent geopolitical events. The Company continues to proactively address impacts to its pricing with third parties, its investment portfolio and its workforce.